|
2021-03-12 |
2021-03-12 |
B
Purchase
|
AKKARAJU SRINIVAS
Non-Executive Director
|
147,000
+29.8%
21.29
USD 3,129,630
|
147,000
+29.8%
|
21.29
|
USD 3,129,630
|
|
|
2021-03-12 |
2021-03-10 |
B
Purchase
|
AKKARAJU SRINIVAS
Non-Executive Director
|
16,559
+3.5%
21.55
USD 356,846
|
16,559
+3.5%
|
21.55
|
USD 356,846
|
|
|
2021-03-12 |
2021-03-10 |
B
Purchase
|
AKKARAJU SRINIVAS
Non-Executive Director
|
73,441
+18.2%
20.83
USD 1,529,776
|
73,441
+18.2%
|
20.83
|
USD 1,529,776
|
|
|
2021-01-05 |
2021-01-05 |
PS
Planned sale
|
Kapadia Sandip
CFO and Treasurer
Officer
|
2,193
-8.4%
24.47
USD 53,663
|
2,193
-8.4%
|
24.47
|
USD 53,663
|
|
|
2020-12-16 |
2020-12-15 |
PS
Planned sale
|
Kapadia Sandip
CFO and Treasurer
Officer
|
1,763
-6.1%
32.78
USD 57,791
|
1,763
-6.1%
|
32.78
|
USD 57,791
|
|
|
2020-08-20 |
2020-08-18 |
S
Sale
|
Campagna Jason
Chief Medical Officer
Officer
|
1,192
-12.0%
47.44
USD 56,543
|
1,192
-12.0%
|
47.44
|
USD 56,543
|
|
|
2020-08-17 |
2020-08-17 |
S
Sale
|
Genextra S.p.A.
Large shareholder
|
1,235,512
-23.6%
46.75
USD 57,760,186
|
1,235,512
-23.6%
|
46.75
|
USD 57,760,186
|
|
|
2020-08-17 |
2020-08-17 |
S
Sale
|
Genextra S.p.A.
Large shareholder
|
126,888
-2.4%
50.15
USD 6,362,913
|
126,888
-2.4%
|
50.15
|
USD 6,362,913
|
|
|
2020-08-17 |
2020-08-17 |
S
Sale
|
Fundaro Paolo
Non-Executive Director
Large shareholder
|
1,235,512
-23.6%
46.75
USD 57,760,186
|
1,235,512
-23.6%
|
46.75
|
USD 57,760,186
|
|
|
2020-08-17 |
2020-08-17 |
S
Sale
|
Fundaro Paolo
Non-Executive Director
Large shareholder
|
126,888
-2.4%
50.15
USD 6,362,913
|
126,888
-2.4%
|
50.15
|
USD 6,362,913
|
|
|
2020-08-17 |
2020-08-17 |
S
Sale
|
Micheli Francesco
Large shareholder
|
1,235,512
-23.6%
46.75
USD 57,760,186
|
1,235,512
-23.6%
|
46.75
|
USD 57,760,186
|
|
|
2020-08-17 |
2020-08-17 |
S
Sale
|
Micheli Francesco
Large shareholder
|
126,888
-2.4%
50.15
USD 6,362,913
|
126,888
-2.4%
|
50.15
|
USD 6,362,913
|
|
|
2020-08-17 |
2020-08-14 |
S
Sale
|
Genextra S.p.A.
Large shareholder
|
54,600
-1.0%
50.55
USD 2,760,112
|
54,600
-1.0%
|
50.55
|
USD 2,760,112
|
|
|
2020-08-17 |
2020-08-14 |
S
Sale
|
Fundaro Paolo
Non-Executive Director
Large shareholder
|
54,600
-1.0%
50.55
USD 2,760,112
|
54,600
-1.0%
|
50.55
|
USD 2,760,112
|
|
|
2020-08-17 |
2020-08-14 |
S
Sale
|
Micheli Francesco
Large shareholder
|
54,600
-1.0%
50.55
USD 2,760,112
|
54,600
-1.0%
|
50.55
|
USD 2,760,112
|
|
|
2020-08-17 |
2020-08-13 |
S
Sale
|
Fundaro Paolo
Non-Executive Director
Large shareholder
|
83,000
-1.5%
52.60
USD 4,365,451
|
83,000
-1.5%
|
52.60
|
USD 4,365,451
|
|
|
2020-08-17 |
2020-08-13 |
S
Sale
|
Genextra S.p.A.
Large shareholder
|
83,000
-1.5%
52.60
USD 4,365,451
|
83,000
-1.5%
|
52.60
|
USD 4,365,451
|
|
|
2020-08-17 |
2020-08-13 |
S
Sale
|
Micheli Francesco
Large shareholder
|
83,000
-1.5%
52.60
USD 4,365,451
|
83,000
-1.5%
|
52.60
|
USD 4,365,451
|
|
|
2020-05-15 |
2020-05-13 |
S
Sale
|
Micheli Francesco
Large shareholder
|
595,578
-9.8%
84.60
USD 50,385,899
|
595,578
-9.8%
|
84.60
|
USD 50,385,899
|
|
|
2020-05-15 |
2020-05-13 |
S
Sale
|
Fundaro Paolo
Non-Executive Director
Large shareholder
|
595,578
-9.8%
84.60
USD 50,385,899
|
595,578
-9.8%
|
84.60
|
USD 50,385,899
|
|
|
2020-05-15 |
2020-05-13 |
S
Sale
|
Genextra S.p.A.
Large shareholder
|
595,578
-9.8%
84.60
USD 50,385,899
|
595,578
-9.8%
|
84.60
|
USD 50,385,899
|
|
|
2020-04-29 |
2020-04-27 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
181
-1.0%
85.95
USD 15,557
|
181
-1.0%
|
85.95
|
USD 15,557
|
|
|
2020-04-10 |
2020-04-09 |
PS
Planned sale
|
Ford David A
Chief Human Resources Officer
Officer
|
58
-0.4%
70.00
USD 4,060
|
58
-0.4%
|
70.00
|
USD 4,060
|
|
|
2020-02-28 |
2020-02-27 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
113
-0.6%
87.62
USD 9,901
|
113
-0.6%
|
87.62
|
USD 9,901
|
|
|
2020-01-27 |
2020-01-27 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
|
723
-3.9%
94.04
USD 67,991
|
723
-3.9%
|
94.04
|
USD 67,991
|
|
|
2020-01-08 |
2020-01-07 |
PS
Planned sale
|
Campagna Jason
Chief Medical Officer
|
732
-10.4%
113.02
USD 82,731
|
732
-10.4%
|
113.02
|
USD 82,731
|
|
|
2020-01-03 |
2019-12-31 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
100
-0.0%
125.00
USD 12,500
|
100
-0.0%
|
125.00
|
USD 12,500
|
|
|
2020-01-03 |
2019-12-31 |
PS
Planned sale
|
Cawkwell Gail
SVP, Med Affairs, Safety & PV
|
262
-1.4%
125.00
USD 32,750
|
262
-1.4%
|
125.00
|
USD 32,750
|
|
|
2019-12-30 |
2019-12-27 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
1,581
-10.0%
123.24
USD 194,842
|
1,581
-10.0%
|
123.24
|
USD 194,842
|
|
|
2019-12-30 |
2019-12-26 |
PS
Planned sale
|
Cawkwell Gail
SVP, Med Affairs, Safety & PV
Officer
|
54
-0.3%
125.00
USD 6,750
|
54
-0.3%
|
125.00
|
USD 6,750
|
|
|
2019-12-30 |
2019-12-26 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
417
-0.1%
125.00
USD 52,125
|
417
-0.1%
|
125.00
|
USD 52,125
|
|
|
2019-12-20 |
2019-12-19 |
PS
Planned sale
|
Campagna Jason
Chief Medical Officer
Officer
|
154
-2.0%
119.45
USD 18,395
|
154
-2.0%
|
119.45
|
USD 18,395
|
|
|
2019-12-02 |
2019-11-27 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
1,040
-6.2%
101.65
USD 105,716
|
1,040
-6.2%
|
101.65
|
USD 105,716
|
|
|
2019-11-27 |
2019-11-26 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
|
4,373
-21.7%
100.00
USD 437,300
|
4,373
-21.7%
|
100.00
|
USD 437,300
|
|
|
2019-11-27 |
2019-11-26 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
35,437
-7.0%
100.00
USD 3,543,700
|
35,437
-7.0%
|
100.00
|
USD 3,543,700
|
|
|
2019-11-27 |
2019-11-25 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
|
1,855
-10.5%
100.00
USD 185,500
|
1,855
-10.5%
|
100.00
|
USD 185,500
|
|
|
2019-11-27 |
2019-11-25 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
14,563
-3.0%
100.00
USD 1,456,300
|
14,563
-3.0%
|
100.00
|
USD 1,456,300
|
|
|
2019-11-19 |
2019-11-19 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
1,550
-9.0%
85.00
USD 131,750
|
1,550
-9.0%
|
85.00
|
USD 131,750
|
|
|
2019-11-19 |
2019-11-19 |
PS
Planned sale
|
Sullivan Ryan T
General Counsel and Secretary
Officer
|
3,829
-14.9%
85.00
USD 325,465
|
3,829
-14.9%
|
85.00
|
USD 325,465
|
|
|
2019-11-19 |
2019-11-19 |
PS
Planned sale
|
Sullivan Ryan T
General Counsel and Secretary
Officer
|
8,325
-24.5%
85.00
USD 707,625
|
8,325
-24.5%
|
85.00
|
USD 707,625
|
|
|
2019-11-15 |
2019-11-13 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
|
946
-5.2%
85.00
USD 80,410
|
946
-5.2%
|
85.00
|
USD 80,410
|
|
|
2019-11-15 |
2019-11-13 |
PS
Planned sale
|
Sullivan Ryan T
General Counsel and Secretary
|
500
-1.9%
85.00
USD 42,500
|
500
-1.9%
|
85.00
|
USD 42,500
|
|
|
2019-10-31 |
2019-10-29 |
PS
Planned sale
|
Bright Lisa
President, International
|
595
-3.1%
75.00
USD 44,625
|
595
-3.1%
|
75.00
|
USD 44,625
|
|
|
2019-10-25 |
2019-10-23 |
PS
Planned sale
|
Ford David A
Chief Human Resources Officer
|
58
-0.5%
70.00
USD 4,060
|
58
-0.5%
|
70.00
|
USD 4,060
|
|
|
2019-09-18 |
2019-09-16 |
PS
Planned sale
|
Ford David A
Chief Human Resources Officer
|
800
-6.5%
70.00
USD 56,000
|
800
-6.5%
|
70.00
|
USD 56,000
|
|
|
2019-08-30 |
2019-08-28 |
B
Purchase
|
AKKARAJU SRINIVAS
Non-Executive Director
|
5,207
+1.3%
60.32
USD 314,086
|
5,207
+1.3%
|
60.32
|
USD 314,086
|
|
|
2019-07-03 |
2019-07-03 |
PS
Planned sale
|
Bright Lisa
President, International
|
595
-2.9%
78.66
USD 46,803
|
595
-2.9%
|
78.66
|
USD 46,803
|
|
|
2019-05-14 |
2019-05-14 |
B
Purchase
|
Benatti Luca
Non-Executive Director
|
1,200
+18.9%
83.50
USD 100,200
|
1,200
+18.9%
|
83.50
|
USD 100,200
|
|
|
2019-05-03 |
2019-05-01 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
2,000
-4.8%
86.28
USD 172,560
|
2,000
-4.8%
|
86.28
|
USD 172,560
|
|
|
2019-04-16 |
2019-04-15 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
|
2,000
-4.8%
95.00
USD 190,000
|
2,000
-4.8%
|
95.00
|
USD 190,000
|
|
|
2019-04-03 |
2019-04-03 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
|
562
-1.4%
115.01
USD 64,636
|
562
-1.4%
|
115.01
|
USD 64,636
|
|
|
2019-04-03 |
2019-04-03 |
PS
Planned sale
|
Bright Lisa
President, International
|
594
-2.8%
115.01
USD 68,316
|
594
-2.8%
|
115.01
|
USD 68,316
|
|
|
2019-03-29 |
2019-03-29 |
PS
Planned sale
|
Fundaro Paolo
|
2,171
-16.3%
107.45
USD 233,272
|
2,171
-16.3%
|
107.45
|
USD 233,272
|
|
|
2019-03-01 |
2019-03-01 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
333
-1.7%
103.16
USD 34,352
|
333
-1.7%
|
103.16
|
USD 34,352
|
|
|
2019-03-01 |
2019-03-01 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
2,000
-4.7%
103.16
USD 206,320
|
2,000
-4.7%
|
103.16
|
USD 206,320
|
|
|
2019-02-21 |
2019-02-19 |
PS
Planned sale
|
AKKARAJU SRINIVAS
Non-Executive Director
|
23,438
-10.0%
128.78
USD 3,018,346
|
23,438
-10.0%
|
128.78
|
USD 3,018,346
|
|
|
2019-02-20 |
2019-02-15 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
2,000
-4.7%
111.51
USD 223,020
|
2,000
-4.7%
|
111.51
|
USD 223,020
|
|
|
2019-01-09 |
2019-01-07 |
PS
Planned sale
|
Bright Lisa
President, International
Officer
|
1,313
-6.5%
104.93
USD 137,773
|
1,313
-6.5%
|
104.93
|
USD 137,773
|
|
|
2019-01-04 |
2019-01-04 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
474
-1.3%
97.48
USD 46,206
|
474
-1.3%
|
97.48
|
USD 46,206
|
|
|
2020-01-03 |
2019-01-03 |
PS
Planned sale
|
Ford David A
Chief Human Resources Officer
|
259
-2.4%
117.16
USD 30,344
|
259
-2.4%
|
117.16
|
USD 30,344
|
|
|
2019-01-03 |
2019-01-03 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
699
-1.8%
97.45
USD 68,118
|
699
-1.8%
|
97.45
|
USD 68,118
|
|
|
2019-01-03 |
2019-01-02 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
2,000
-4.9%
98.28
USD 196,560
|
2,000
-4.9%
|
98.28
|
USD 196,560
|
|
|
2018-12-19 |
2018-12-17 |
PS
Planned sale
|
Shapiro David
Chief Medical Officer
Officer
|
2,000
-4.9%
106.62
USD 213,240
|
2,000
-4.9%
|
106.62
|
USD 213,240
|
|
|
2018-12-06 |
2018-12-04 |
S
Sale
|
Bright Lisa
President, International
Officer
|
300
-1.4%
111.00
USD 33,300
|
300
-1.4%
|
111.00
|
USD 33,300
|
|
|
2018-12-06 |
2018-12-03 |
S
Sale
|
Bright Lisa
President, International
Officer
|
200
-0.9%
113.22
USD 22,645
|
200
-0.9%
|
113.22
|
USD 22,645
|
|
|
2018-12-06 |
2018-12-03 |
S
Sale
|
Bright Lisa
President, International
Officer
|
700
-3.1%
112.12
USD 78,486
|
700
-3.1%
|
112.12
|
USD 78,486
|
|
|
2018-12-06 |
2018-12-03 |
S
Sale
|
Bright Lisa
President, International
Officer
|
3,800
-14.5%
111.23
USD 422,691
|
3,800
-14.5%
|
111.23
|
USD 422,691
|
|
|
2018-12-03 |
2018-11-29 |
S
Sale
|
Genextra S.p.A.
|
750,000
-11.0%
105.07
USD 78,802,500
|
750,000
-11.0%
|
105.07
|
USD 78,802,500
|
|
|
2018-12-03 |
2018-11-29 |
S
Sale
|
Micheli Francesco
|
750,000
-11.0%
105.07
USD 78,802,500
|
750,000
-11.0%
|
105.07
|
USD 78,802,500
|
|
|
2018-11-29 |
2018-11-29 |
PS
Planned sale
|
Weyer Christian
EVP, Research & Development
Officer
|
1,343
-7.8%
113.78
USD 152,807
|
1,343
-7.8%
|
113.78
|
USD 152,807
|
|
|
2018-11-16 |
2018-11-16 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
1,988
-0.3%
103.29
USD 205,333
|
1,988
-0.3%
|
103.29
|
USD 205,333
|
|
|
2018-11-16 |
2018-11-16 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
7,839
-1.4%
102.61
USD 804,374
|
7,839
-1.4%
|
102.61
|
USD 804,374
|
|
|
2018-11-16 |
2018-11-16 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
7,949
-1.4%
101.48
USD 806,687
|
7,949
-1.4%
|
101.48
|
USD 806,687
|
|
|
2018-11-16 |
2018-11-16 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
9,830
-1.7%
100.38
USD 986,735
|
9,830
-1.7%
|
100.38
|
USD 986,735
|
|
|
2018-11-16 |
2018-11-15 |
PS
Planned sale
|
Pruzanski Mark
President & CEO
Executive Director
|
3,521
-0.6%
101.13
USD 356,088
|
3,521
-0.6%
|
101.13
|
USD 356,088
|
|
